QuantaMatrix Inc.

A317690

KR7317690006

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 23:00:00 18/06/2024 BST			5-day change	1st Jan Change
4,140 ^KRW	-2.36%		-6.76%	-11.16%

03-08	QuantaMatrix Inc. announced that it has received KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	CI
03-07	QuantaMatrix Inc. announced that it expects to receive KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	CI

QuantaMatrix Inc. has filed an IPO.

April 14, 2020 at 05:00 am

QuantaMatrix Inc. has filed an IPO.

Security Name: Shares
Security Type: Common Stock
PriceRange: KRW 21200 to KRW 26500

Transaction Features: Sponsor Backed Offering

Latest news about QuantaMatrix Inc.

QuantaMatrix Inc. announced that it has received KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	03-07	CI
QuantaMatrix Inc. announced that it expects to receive KRW 17.5 billion in funding from Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., The Korea Securities Finance Corporation, KB Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., Samsung Securities Co., Ltd.	03-06	CI
QuantaMatrix Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23	CI
QuantaMatrix Inc.(KOSDAQ:A317690) dropped from S&P Global BMI Index	19/09/22	CI
Limbach Group Adopts QuantaMatrix dRAST in Routine Clinical Use	14/12/21	CI
QuantaMatrix Inc. announced that it has received KRW 18.4470005 billion in funding from The Ezrah Charitable Trust, Marks And Company LLC, Mission Street Pte Limited and other investor	11/11/21	CI
QuantaMatrix Inc. announced that it expects to receive KRW 18.4470005 billion in funding from The Ezrah Charitable Trust, Marks And Company LLC, Mission Street Pte Limited and other investor	17/10/21	CI
QuantaMatrix Inc.(KOSDAQ:A317690) added to S&P Global BMI Index	21/06/21	CI
CELLnLIFE Inc announced that it has received funding from Quratis Inc., GAMEVIL Inc., QuantaMatrix Inc.	30/05/21	CI
QuantaMatrix Inc. has completed an IPO in the amount of KRW 43.5285 billion.	27/11/20	CI
QuantaMatrix Inc. has filed an IPO.	14/04/20	CI

QuantaMatrix Inc is a Korean-based company engaged in the development and production of in vitro diagnostics (IVD) medical devices. The Company's main products include a multi-diagnostic unique test platform, micro disc, antimicrobial susceptibility testing sepsis diagnostic equipment, molecular immunity diagnosis automation platform, rapid antituberculosis susceptibility testing equipment, rapid antituberculosis susceptibility testing kits, and others. In addition, the Company sells covid kits and engages in research and development of microbial diagnostic products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
QUANTAMATRIX INC.	-11.16%	49.56M
BIOMÉRIEUX	-10.69%	11.41B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-11.02%	7.53B
LANTHEUS HOLDINGS, INC.	+30.85%	5.62B
DIASORIN S.P.A.	+4.89%	5.54B
AUTOBIO DIAGNOSTICS CO., LTD.	-16.28%	3.82B
ANDON HEALTH CO., LTD.	+8.39%	2.6B
10X GENOMICS, INC.	-64.67%	2.37B
VITROLIFE AB	-10.17%	2.26B
MYRIAD GENETICS, INC.	+24.87%	2.16B